These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37103677)

  • 1. Effects of IL-6/IL-6R axis alterations in serum, plasma and cerebrospinal fluid with the schizophrenia: an updated review and meta-analysis of 58 studies.
    González-Castro TB; Tovilla-Zárate CA; Juárez-Rojop IE; Hernández-Díaz Y; López-Narváez ML; Ortiz-Ojeda RF
    Mol Cell Biochem; 2024 Mar; 479(3):525-537. PubMed ID: 37103677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients.
    Sasayama D; Wakabayashi C; Hori H; Teraishi T; Hattori K; Ota M; Ishikawa M; Arima K; Higuchi T; Amano N; Kunugi H
    J Psychiatr Res; 2011 Nov; 45(11):1439-44. PubMed ID: 21700295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.
    Orlovska-Waast S; Köhler-Forsberg O; Brix SW; Nordentoft M; Kondziella D; Krogh J; Benros ME
    Mol Psychiatry; 2019 Jun; 24(6):869-887. PubMed ID: 30116031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin levels in individuals with schizophrenia are high in cerebrospinal fluid but low in serum: A systematic review and meta-analysis : Oxytocin and Schizophrenia.
    Hernández-Díaz Y; González-Castro TB; Tovilla-Zárate CA; López-Narváez ML; Genis-Mendoza AD; Castillo-Avila RG; Ramos-Méndez MÁ; Juárez-Rojop IE
    Metab Brain Dis; 2021 Dec; 36(8):2415-2424. PubMed ID: 34495462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
    Bagli M; Papassotiropoulos A; Hampel H; Becker K; Jessen F; Bürger K; Ptok U; Rao ML; Möller HJ; Maier W; Heun R
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):44-8. PubMed ID: 12664314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid and serum protein levels of tumour necrosis factor-alpha (TNF-alpha) interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R gp80) in multiple sclerosis patients.
    Vladić A; Horvat G; Vukadin S; Sucić Z; Simaga S
    Cytokine; 2002 Oct; 20(2):86-9. PubMed ID: 12445803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients.
    Stelmasiak Z; Kozioł-Montewka M; Dobosz B; Rejdak K
    Med Sci Monit; 2001; 7(5):914-8. PubMed ID: 11535934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus.
    Kado S; Nagase T; Nagata N
    Acta Diabetol; 1999 Jun; 36(1-2):67-72. PubMed ID: 10436255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.
    Padberg F; Feneberg W; Schmidt S; Schwarz MJ; Körschenhausen D; Greenberg BD; Nolde T; Müller N; Trapmann H; König N; Möller HJ; Hampel H
    J Neuroimmunol; 1999 Oct; 99(2):218-23. PubMed ID: 10505978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of cytokines genes (IL-6 and IL-10) with the susceptibility to schizophrenia: A systematic review and meta-analysis.
    Beatriz González-Castro T; Alfonso Tovilla-Zárate C; Esther Juárez-Rojop I; Hernández-Díaz Y; Lilia López-Narváez M; Felicita Ortiz-Ojeda R
    Brain Res; 2024 Jan; 1822():148667. PubMed ID: 37923001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 in irritable bowel syndrome: A systematic review and meta-analysis of IL-6 (-G174C) and circulating IL-6 levels.
    Bashashati M; Moradi M; Sarosiek I
    Cytokine; 2017 Nov; 99():132-138. PubMed ID: 28886490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum interleukin-6 in schizophrenia: A system review and meta-analysis.
    Zhou X; Tian B; Han HB
    Cytokine; 2021 May; 141():155441. PubMed ID: 33529887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.
    Sasayama D; Hattori K; Wakabayashi C; Teraishi T; Hori H; Ota M; Yoshida S; Arima K; Higuchi T; Amano N; Kunugi H
    J Psychiatr Res; 2013 Mar; 47(3):401-6. PubMed ID: 23290488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H; Robak E
    Mediators Inflamm; 1998; 7(5):347-53. PubMed ID: 9883970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis.
    Gallego JA; Blanco EA; Husain-Krautter S; Madeline Fagen E; Moreno-Merino P; Del Ojo-Jiménez JA; Ahmed A; Rothstein TL; Lencz T; Malhotra AK
    Schizophr Res; 2018 Dec; 202():64-71. PubMed ID: 30025760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.
    Lin A; Kenis G; Bignotti S; Tura GJ; De Jong R; Bosmans E; Pioli R; Altamura C; Scharpé S; Maes M
    Schizophr Res; 1998 Jun; 32(1):9-15. PubMed ID: 9690329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of interleukin-10 polymorphisms with schizophrenia: a meta-analysis.
    Gao L; Li Z; Chang S; Wang J
    PLoS One; 2014; 9(3):e90407. PubMed ID: 24603720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Interleukin-6 and Its Receptor in Endometriosis.
    Li S; Fu X; Wu T; Yang L; Hu C; Wu R
    Med Sci Monit; 2017 Aug; 23():3801-3807. PubMed ID: 28779573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 expression is increased in patients with tuberculosis: A systematic review and meta-analysis.
    He J; Song L; Zheng P
    Medicine (Baltimore); 2023 Jun; 102(24):e34041. PubMed ID: 37327256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.